Pharmacotherapy of inflammatory bowel diseases
| dc.contributor.advisor | Pórszász, Róbert | |
| dc.contributor.advisordept | Debreceni Egyetem::Általános Orvostudományi Kar::Farmakológiai és Farmakoterápiai Intézet | hu_HU |
| dc.contributor.author | Blum, Idan | |
| dc.contributor.department | DE--Általános Orvostudományi Kar | hu_HU |
| dc.contributor.opponent | Drimba, László | |
| dc.contributor.opponent | Szentmiklósi, József András | |
| dc.contributor.opponentdept | Kenézy Kórház Központi Aneszteziológiai és Intenzív Terápiás Osztály | hu_HU |
| dc.contributor.opponentdept | Debreceni Egyetem::Általános Orvostudományi Kar::Farmakológiai és Farmakoterápiai Intézet | hu_HU |
| dc.date.accessioned | 2018-11-19T11:21:34Z | |
| dc.date.available | 2018-11-19T11:21:34Z | |
| dc.date.created | 2017 | |
| dc.description.abstract | IBD is a multifactorial disorder of unknown etiology. The treatment of IBD in any given patient may have several different goals, such as relief of symptoms, induction of remission in patients with active disease, prevention of relapse, healing of fistulas, and avoidance of emergency surgery. The current drug treatments include the use of anti-inflammatory agents and agents that reduce the symptoms associated with IBD. Therapy may be modified to some extent based on the severity and location of the disease. | hu_HU |
| dc.description.course | általános orvos | hu_HU |
| dc.description.courselang | angol | hu_HU |
| dc.description.degree | egységes, osztatlan | hu_HU |
| dc.format.extent | 53 | hu_HU |
| dc.identifier.uri | http://hdl.handle.net/2437/259276 | |
| dc.language.iso | en | hu_HU |
| dc.subject | inflammatory bowel diseases | hu_HU |
| dc.subject.dspace | DEENK Témalista::Orvostudomány | hu_HU |
| dc.title | Pharmacotherapy of inflammatory bowel diseases | hu_HU |